News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Taiho Oncology Europe Announces the Availability of Lytgobi® (Futibatinib) in Germany for the Treatment of Cholangiocarcinoma.
Wednesday, June 12, 2024Taiho Oncology Europe GmbH has announced the launch of Lytgobi in Germany following its conditional approval across the European Union Lytgobi is a new oral medication
Dandelion Science and the Wyss Center in Geneva Launch AI Partnership to Innovate Non-Invasive Brain Therapies
Wednesday, June 12, 2024The Wyss Center for Bio and Neuroengineering in Geneva and Dandelion Science have announced a partnership to develop a cuttingedge generative AI neuromodulation platform This collaboration
Eilean Therapeutics Receives FDA Clearance for IND Application of Lomonitinib in Treating Acute Myeloid Leukemia
Tuesday, June 11, 2024Eilean Therapeutics LLC is pleased to announce that the US Food and Drug Administration has approved the Investigational New Drug application for lomonitinib This approval allows the company
Hoth Therapeutics and Wise Systems International SRL Form Alliance to Leverage AI in Drug Discovery
Tuesday, June 11, 2024Hoth Therapeutics Inc a company dedicated to patientfocused biopharmaceutical solutions announced a new partnership with Wise Systems International SRL This collaboration
European Commission Grants Approval for Roche's Alecensa as the Premier Targeted Adjuvant Therapy for Early-Stage Lung Cancer with ALK Mutation
Monday, June 10, 2024Roche has received approval from the European Commission for Alecensa as an adjuvant treatment following surgery for adult patients with ALKpositive nonsmall cell lung cancer
Helix Launches Combined Clinical and Genomic Data for Disorders Related to Cardiovascular, Metabolic, Immunological, and Inflammatory Conditions
Saturday, June 08, 2024Helix a pioneer in population genomics is rolling out new clinicogenomic datasets to enhance precision medicine in drug discovery and development These cohorts created through extensive collaborations
Agomab Secures FDA Orphan Drug Status for AGMB-447 to Address Idiopathic Pulmonary Fibrosis
Friday, June 07, 2024Agomab Therapeutics NV announced today that its inhaled small molecule inhibitor of ALK AGMB has received Orphan Drug Designation from the US Food and Drug Administration
BridgeBio Oncology Starts Phase 1 ONKORAS-101 Trial with BBO-8520 for KRASG12C Mutant Non-Small Cell Lung Cancer
Friday, June 07, 2024BridgeBio Oncology Therapeutics a clinicalstage biopharmaceutical company focused on RASpathway cancers has announced the commencement of the ONKORAS clinical trial marking the administration
Pierre Fabre Laboratories Files IND for PFL-002/VERT-002, Targeting Treatment of Solid Tumors and MET-Altered Non-Small Cell Lung Cancer
Thursday, June 06, 2024Pierre Fabre Laboratories has submitted an application for investigational new drug approval to the US Food and Drug Administration to begin a Phase III clinical trial with PFLVERT aimed
QUANTRO Therapeutics Achieves Significant Milestone in Collaboration with Boehringer Ingelheim for the Development of Novel Cancer Therapies
Wednesday, June 05, 2024Quantro Therapeutics has achieved a significant milestone in its collaboration with Boehringer Ingelheim Through the use of Quantros proprietary QUANTROseq Transcriptional Fingerprint technology
